Abstract
Variants in the Glucokinase Regulator (GCKR) gene are increasingly being detected with growing applications of genomic sequencing technologies. Despite the crucial roles of the GCKR gene in energy homeostasis, the clinical applications of GCKR variants are currently limited. We observed that a large proportion of GCKR variants that are available in gnomAD database (https://gnomad.broadinstitute.org/) lacked adequate evidence of pathogenicity or benign impact. We highlight the clinical need for an improved understanding of GCKR variants by presenting 2 compelling cases of unrelated families (3 individuals in total) who harbor rare GCKR variants in the context of cornea arcus and hyperlipidemia. Our observations underscore the burgeoning need for functional as well as family segregation studies to facilitate the clinical applications of GCKR variants.
| Original language | English |
|---|---|
| Journal | Clinical Medicine Insights: Endocrinology and Diabetes |
| Volume | 19 |
| Early online date | 6 May 2026 |
| DOIs | |
| Publication status | Published - May 2026 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cornea Arcus and Dyslipidemia in Unrelated Adults with Monoallelic Germline Variants in theGlucokinase RegulatorGene
- dyslipidemia
- GCKR
- GKRP
- hyperlipidemia
- variants
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
Fingerprint
Dive into the research topics of 'Cornea Arcus and Dyslipidemia in Unrelated Adults With Monoallelic Germline Variants in the Glucokinase Regulator Gene'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver